Stock listing

Fluoguide A/s

Selected listing: 96X · FWB · EUR · DE

Fluoguide A/s (Frankfurt:96X), Health Technology. Latest release Oct 5, 2026: FluoGuide Enrolls First Patient in U.S. Phase 2 Trial of FG001 in High-Grade…

96X:FWBEURDEUpdated October 3, 2026
Fluoguide A/s logo
Ticker
Frankfurt:96X
Asset type
Stock
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
Frankfurt
Currency
EUR

Latest news from Fluoguide A/s

FluoGuide Enrolls First Patient in U.S. Phase 2 Trial of FG001 in High-Grade Glioma

October 5, 2026

FluoGuide Enters Collaboration with Leica Microsystems, a World Leading Medical Technology Company

October 2, 2026

FluoGuide A/S publishes interim report for Q2 2026

August 25, 2026

Invitation to FluoGuide A/S live webcast on 25 August 2026

August 12, 2026

FluoGuide A/S publishes interim report for Q1 2026

May 27, 2026

All Fluoguide A/s news →

Research Fluoguide A/s

Fluoguide A/s company profile

View the public company page for Fluoguide A/s on 6ix.

Fluoguide A/s news

Read company news and market updates connected to Fluoguide A/s.

Fluoguide A/s investor events

Find investor webinars, events, and replay context for Fluoguide A/s.

Alternate listings

FLUO:OMXSTO

SE · SEK

Alternate listing for Fluoguide A/s; the primary context on this page is 96X:FWB.